Greenbrier Companies' (NYSE:GBX) Shareholders Will Receive A Bigger Dividend Than Last Year
The board of The Greenbrier Companies, Inc. (NYSE:GBX) has announced that the dividend on 13th of May will be increased to $0.32, which will be 6.7% higher than last year's payment of $0.30 which covered the same period. This makes the dividend yield 2.7%, which is above the industry average.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
While it is great to have a strong dividend yield, we should also consider whether the payment is sustainable. Greenbrier Companies is quite easily earning enough to cover the dividend, however it is being let down by weak cash flows. In general, we consider cash flow to be more important than earnings, so we would be cautious about relying on the sustainability of this dividend.
Over the next year, EPS is forecast to expand by 2.1%. If the dividend continues along recent trends, we estimate the payout ratio will be 22%, which is in the range that makes us comfortable with the sustainability of the dividend.
See our latest analysis for Greenbrier Companies
The company has been paying a dividend for a long time, and it has been quite stable which gives us confidence in the future dividend potential. Since 2015, the annual payment back then was $0.60, compared to the most recent full-year payment of $1.20. This works out to be a compound annual growth rate (CAGR) of approximately 7.2% a year over that time. Dividends have grown at a reasonable rate over this period, and without any major cuts in the payment over time, we think this is an attractive combination as it provides a nice boost to shareholder returns.
Some investors will be chomping at the bit to buy some of the company's stock based on its dividend history. Greenbrier Companies has seen EPS rising for the last five years, at 26% per annum. Earnings have been growing rapidly, and with a low payout ratio we think that the company could turn out to be a great dividend stock.
Overall, this is probably not a great income stock, even though the dividend is being raised at the moment. With cash flows lacking, it is difficult to see how the company can sustain a dividend payment. Overall, we don't think this company has the makings of a good income stock.
Market movements attest to how highly valued a consistent dividend policy is compared to one which is more unpredictable. However, there are other things to consider for investors when analysing stock performance. Just as an example, we've come across 3 warning signs for Greenbrier Companies you should be aware of, and 1 of them is significant. Is Greenbrier Companies not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
30 minutes ago
- Business Wire
Law Offices of Frank R. Cruz Encourages Vestis Corporation (VSTS) Investors To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Vestis Corporation ('Vestis' or the 'Company') (NYSE: VSTS) securities between , inclusive (the 'Class Period'). Vestis investors have until August 8, 2025 to file a lead plaintiff motion. Law Offices of Frank R. Cruz Encourages Vestis Corporation (VSTS) Investors To Inquire About Securities Fraud Class Action Share IF YOU SUFFERED A LOSS ON YOUR VESTIS CORPORATION (VSTS), INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT. You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at info@ by telephone at (310) 914-5007, or visit our website at What Happened? On May 7, 2025, Vestis released its second quarter fiscal 2025 financial results and revised its prior growth and revenue guidance for 2025, providing guidance for the third quarter, falling significantly below market expectations. The Company explained that the poor results were partially due to 'lost business in excess of new business' but primarily on 'lower adds over stops, which is how [it] describe[s] volumes changes with [its] existing customers.' On this news, Vestis's stock price fell $3.27, or 37.5%, to close at $5.44 per share on May 7, 2025, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company was not equipped to achieve its growth guidance as the realization of these efforts instead resulted in a significant decline of revenue from existing customers; and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. Contact Us To Participate or Learn More: If you purchased Vestis securities, wish to learn more about this action, or have any questions concerning this announcement or your rights or interests with respect to these matters, please click HERE or contact us at: Law Offices of Frank R. Cruz 2121 Avenue of the Stars, Suite 800 Telephone: 310-914-5007 Email: info@ Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Business Wire
40 minutes ago
- Business Wire
Visa Releases Money Travels: 2025 Digital Remittances Adoption Report for North America
SAN FRANCISCO--(BUSINESS WIRE)--Visa Inc. (NYSE: V) today unveiled its Money Travels: 2025 Digital Remittances Adoption Report, highlighting the growing influence of digital remittance applications in North America, driven by convenience, security, and user-friendly experiences. "Digital remittances are being embraced across North America due to their ease of use, reliability, and improved security," said Ben Ellis, SVP and Head of Visa B2B Connect. "As digital remittances become more prevalent, transparency and customer satisfaction will be essential to meet evolving consumer expectations." Key Findings for North America Digital App Dominance: App Preference: In the U.S., 69% of surveyed respondents prefer using digital apps for sending remittances, while 61% prefer using them for receiving. In Canada, the preference is similarly strong, with 65% preferring digital apps for both sending and receiving. Traditional Methods Lag: The use of traditional methods like cash or checks is declining, with only 5% to 8% of respondents in the U.S. and 3% to 6% of respondents in Canada favoring these options. Ease of Use: Ease and Peace of Mind: A significant portion of surveyed respondents in the U.S. (38%/34%) and Canada (45%/40%) appreciate the ease of using digital apps for remittances, while security and privacy are crucial for 36% of U.S. survey respondents and 40% of Canadian survey respondents. Primary Reasons: Unexpected needs (36% in the U.S., 32% in Canada) remain the top reason for sending remittances for survey respondents, followed by holidays and special occasions. Pain Points: Fees: High fees remain a concern, with 27% of U.S. and 30% of Canadian respondents citing this as a major issue when sending digitally. Traditional methods and hidden fees: 35% of U.S. and 28% of respondents said they had experienced some kind of hidden fee when using cash, checks or money orders. With one billion people globally involved in remittances and stable engagement in North America, Visa continues to innovate with solutions like stablecoins to help enhance cost-efficiency and broaden financial access. "Digital remittances have revolutionized the industry and offer consumers more options than ever before to send funds, but there's still room for further innovation," added Luba Goldberg, SVP, Visa Direct Product. "Continued expansion of digital options to send money around the world, and emerging technologies such as stablecoins, are poised to improve the speed, cost, and security of international remittances." About Visa Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions, and government entities across more than 200 markets. Our mission is to connect the world through the most innovative, convenient, reliable, and secure payments network, enabling individuals, businesses, and economies to thrive. We believe that economies that include everyone everywhere uplift everyone everywhere, and see access as foundational to the future of money movement. Learn more at
Yahoo
an hour ago
- Yahoo
Watch the Surge of Insider Buying at UnitedHealth Group
June 16, 2025 (Maple Hill Syndicate) You might think UnitedHealth Group Inc. (NYSE:UNH) would be on the ropes. One of its top executives was shot dead, its CEO resigned for personal reasons, and the federal government is probing its billing practices. But executives at this health-insurance and health-services giant apparently don't think doom is knocking at the door. Five of them have bought the company's stock in the past few weeks, including CEO Stephen Hemsley. Warning! GuruFocus has detected 4 Warning Sign with UNH. Barrage The barrage of bad news that has hit United Health this year is remarkable. Here's a chronology of some of the events that have rocked the company in the past six months. On December 4, 2024, a gunman shot and killed Brian Thompson, the CEO of UnitedHealthcare, the company's insurance arm and biggest component. Five days later, police arrested Luigi Mangione, a 26-year- old cum laude graduate of University of Pennsylvania with a master's degree in computer science. Shell casings at the scene of the crime bore the words delay, deny, depose. A number of Americans expressed more outrage against insurance companies than they did against the murder. On May 13, UnitedHealth Group said that CEO Andrew Witty had resigned for personal reasons. On May 14, the Wall Street Journal reported that the U.S. Department of Justice is investigating the company for possible criminal Medicare fraud. The company said it hasn't been notified of any investigation. In the past half-year, the stock has declined from well over $600 to the present price of about $313. Buyers On May 16, Hemsley paid $25 million to buy 86,700 shares of the giant health-insurance and health-care company. That was the largest purchase by a corporate insider at any company in May and early June. He served as UnitedHealth's CEO from 2006 to 2017. He resumed that office in May, taking over from Witty. After his big purchase in May, Hemsley now owns 1,112,339 shares, worth about $349 million at the June 13 closing price of $313.53. John Rex, the company's president and chief financial officer, spent close to $5 million on May 16 to add to his holdings, now worth about $66 million. Three directors, Kristen Gil, John Noseworthy and Timothy Patrick Flynn, also bought some shares on May 14 and 15. Punished Has this stock been punished too harshly? In my opinion, yes. UnitedHealth Group hasn't had a loss in the past 30 years. In the past decade, its revenue and earnings have grown at double-digit rates, averaging more than 11% a year for revenue and 17% a year for earnings. The stock now fetches a down-to-earth multiple of 13 times earnings. The typical multiple in the past ten years has been close to 22. The balance sheet doesn't look bad either. The company's debt is about 86% of stockholders' equity, which is within the band I consider okay. The company's profitability looks strong. I consider a 15% return on stockholders' equity good, and 20% excellent. UnitedHealth Group in the past four quarters has been 24%, and it has been above 20% in seven of the past eight years. It's worth noting that the recent buying represents a trend reversal. From June 2022 through the end of 2024, no insiders bought shares but several sold. This year, almost all of the activity has been on the buy side. My guess, therefore, is that Hemsley and the other UnitedHealth executive will end up being glad about their May purchases. The Record Today's column is the 74th one I've written about insiders' purchases and sales. I can tabulate one-year results for 64 of them all those from beginning of 1999 through a year ago. A year ago, I recommended Globe Life Inc. (NYSE:GL) and Skyworks Solutions Inc. (NASDAQ:SWKS). The former rose 50.3% but the latter slumped 19.5%. For the same period, the Standard & Poor's 500 Total Return Index returned 14.5% Stocks that I recommended based on insider buys have returned an average of 9.2% a year decent, but 1.3 percentage points less than the index. Stocks that I said to avoid, even though insiders were buying, have under-performed the index by 24.3 percentage points. Stocks where I noted insider buying, but made no comment (or an ambiguous comment) have beaten the index by 14.1 percentage points. Stocks where I noted insider selling have done 2.3 points worse than the index. Bear in mind that my column results are hypothetical and shouldn't be confused with results I obtain for clients. Also, past performance doesn't predict the future. Disclosure: I own UnitedHealth Group shares personally and for many of my clients. John Dorfman is chairman of Dorfman Value Investments in Boston. His firm of clients may own or trade securities discussed in this column. He can be reached at jdorfman@ This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
